• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > MP Advisors
Publisher
Filter

MP Advisors Report List

madv
MP Advisors is a Consultancy firm with an exclusive focus on Pharmaceuticals / Biotechnology sectors in the US, Europe, India, Japan and Russia. It was operating earlier as an international affiliate of Mehta Partners LLC since 1996. Today it has a highly motivated, qualified team of PhD's, MBA's and Pharmacist who apply their domain knowledge to develop proprietary data bases, understand dynamic regulatory laws across geographies, track and analyze latest trends in drug development, clinical trials and specific diseases. MP Advisors has insightful information on more than 200 pharma and Biotech companies around the globe as well as publishes reports on Key Opinion Leaders (Physician’s view) assessment, therapy class review of several classes (e.g. Oral anticoagulants, Hepatitis C, Obesity, Novel Drug Delivery systems, Biosimilars etc.), India and Japan generic opportunities and Paragraph IV Opportunities.

Filter
Title Search
1 - 10 of 10 Products Sort by Display
Japan Biosimilars- Landscape Today Outlook Tomorrow - "Biosame" entry, uninterrupted supply and companies' strong front-end footprint requirement makes it distinct
Published by
MP Advisors
Product code
920744
Published
January 6, 2020
Content info
156 Pages
Price
USD 4500
Sample available
*
Published by
MP Advisors
Product code
565345
Published
October 13, 2017
Content info
104 Pages
Price
USD 4000
Sample available
Japan Biosimilars - A start of Authorized Biosimilar Era?
Published by
MP Advisors
Product code
541442
Published
August 14, 2017
Content info
128 Pages
Price
USD 4000
Sample available
Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a "Watchful Waiting" and Resistance Population
Published by
MP Advisors
Product code
430711
Published
February 1, 2017
Content info
200 Pages
Price
USD 4500
Sample available
Pain Management - New Discoveries And Treatment Options In Abuse Deterrent Era
Published by
MP Advisors
Product code
368679
Published
September 1, 2016
Content info
135 Pages
Price
USD 3500
Sample available
Large Cap Pharma US & EU Outlook 2016: Maximizing Their Strength On Fewer Therapy Class, Personalized Medicine, Novel Target And Biosimilars For Future Growth
Published by
MP Advisors
Product code
355096
Published
March 17, 2016
Content info
97 Pages
Price
USD 2000
Sample available
India Pharma Outlook 2016: Milestones to Watch - Growth from Exports and Domestic Getting Better, Implementation of Policies under "Make-in-India", Overture of A New Ministry
Published by
MP Advisors
Product code
355095
Published
March 17, 2016
Content info
Price
USD 1500
Sample available
Japan Pharma Outlook 2016:  JP Giants leaning in for becoming a Speciality Global Pharma
Published by
MP Advisors
Product code
355094
Published
March 10, 2016
Content info
91 Pages
Price
USD 2500
Sample available
Rising Stars Outlook 2016: New Emergence of Potential Tx & Dx Options could transform the Current Landscape for Liver Diseases (NASH)
Published by
MP Advisors
Product code
355093
Published
February 1, 2016
Content info
56 Pages
Price
USD 2000
Sample available
*
Published by
MP Advisors
Product code
348143
Published
January 4, 2016
Content info
101 Pages
Price
USD 4000
Sample available